PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
暂无分享,去创建一个
[1] C. McCollum,et al. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. , 1991, Journal of vascular surgery.
[2] C. McCollum,et al. The influence of smoking and plasma factors on prosthetic graft patency. , 1990, European journal of vascular surgery.
[3] A. Nicolaides,et al. Femorodistal vein bypass graft stenoses , 1988, The British journal of surgery.
[4] Van Vroonhoven Tj,et al. PTFE versus human umbilical vein in above knee femoro-popliteal bypass. Early results of a randomized clinical trial. , 1988 .
[5] A. Dardik,et al. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. , 1988, Journal of vascular surgery.
[6] L. Norgren,et al. Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. , 1987, Journal of vascular surgery.
[7] Buchardt Hansen Hj,et al. Umbilical vein bypass in patients with severe lower limb ischemia: a report of 121 consecutive cases. , 1985 .
[8] F. Jarrett,et al. The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up. , 1984, Annals of surgery.
[9] J. May,et al. Limitations of human umbilical vein grafts. , 1984, Surgery.
[10] D. Raithel,et al. Late results with Dardik-biograft in peripheral arterial surgery. , 1984, The Journal of cardiovascular surgery.
[11] C. Mccollum,et al. Does 111indium‐platelet deposition predict patency in prosthetic arterial grafts? , 1983, The British journal of surgery.
[12] W. Abbott,et al. Femoropopliteal and tibioperoneal artery reconstruction using human umbilical vein. , 1983, Archives of surgery.
[13] J. S. Yao,et al. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. , 1982, Surgery.
[14] R. Green,et al. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. , 1982, Surgery.
[15] B. Dubner,et al. Comparative review of early and intermediate patency rates of polytetrafluoroethylene and autogenous saphenous vein grafts for lower extremity ischemia. , 1981, Surgery.
[16] J. Sladen,et al. Experience with 130 polytetrafluoroethylene grafts. , 1981, American journal of surgery.
[17] R. Weisel,et al. Comparison of conduits for leg revascularization. , 1981, Surgery.
[18] F. Veith,et al. Three year experience with expanded polytetrafluoroethylene arterial grafts for limb salvage. , 1980, American journal of surgery.
[19] F. Veith,et al. Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation. , 1980, Surgery.
[20] I. Dardik,et al. Three‐year experience with glutaraldehyde‐stabilized umbilical vein for limb salvage , 1980, The British journal of surgery.
[21] I. Dardik,et al. Successful Arterial Substitution with Modified Human Umbilical Vein , 1976, Annals of surgery.
[22] M. Saigusa,et al. A new vascular prosthesis for a small caliber artery. , 1973, Surgery.